AHA Center partners with Brainomix and MicroTransponder for health innovation

Dr. Ronald Klatz, MD, DO Worldhealth.net An #AI #algorithm now detects #cancer in blood samples in just 10 minutes, no human input needed. It spots rare cells with 99% accuracy, revolutionizing early #diagnosis and #treatment. A major leap for liquid biopsy and patient care. #worldhealth #medtech #biotech #cancerresearch #machinelearning #digitalhealth #innovation #antiaging #regenerativemedicine #medicine #health #clinicalresearch #wellness https://lnkd.in/gUNaVsUx

We're excited to share that AI/ML Innovations Inc.'s subsidiary NeuralCloud Solutions has partnered with Heartdent Center Ltd. to launch an innovative pilot project in Jamaica. This collaboration will test CardioYield™, paired with a single-lead ECG wearable chest strap. The initiative specifically targets the expansion of affordable cardiac care access in Jamaica, where cardiovascular diagnostic options can be limited. By leveraging AI technology, the CardioYield™ platform aims to deliver accurate, accessible Holter diagnostics to address critical cardiovascular disease challenges in the region. This promising partnership was introduced by collaborator Wayne Isaacs, bringing together technological innovation and healthcare expertise to potentially transform cardiac care delivery models. Read the Full Press Release: https://lnkd.in/eCEVctp7

Dr. Ronald Klatz, MD, DO Worldhealth.net An #AI #algorithm now detects #cancer in blood samples in just 10 minutes, no human input needed. It spots rare cells with 99% accuracy, revolutionizing early #diagnosis and #treatment. A major leap for liquid biopsy and patient care. #worldhealth #medtech #biotech #cancerresearch #machinelearning #digitalhealth #innovation #antiaging #health #regenerativemedicine #medicine #clinicalresearch #wellness https://lnkd.in/gPrAw-r7

We’re excited to continue our 25 Icons & Innovators series with a spotlight on MedRhythms, Inc. a leader in digital therapeutics for neurorehabilitation. Co-founders Owen McCarthy and Brian Harris have redefined stroke and neuro rehab with sensor-driven rhythmic auditory stimulation, bridging neuroscience and technology to deliver scalable, evidence-based care. Their vision and leadership have helped MedRhythms overcome complex approval and reimbursement challenges, setting a new standard in digital health. #digitaltherapeutics #neurorehab #medtechinnovation #stroke

We’re proud to announce that Life Molecular Imaging (LMI), a Lantheus company, has partnered with SOFIE to expand access to our established amyloid PET tracer—now available from SOFIE’s Decatur, IL manufacturing site.     This strategic expansion strengthens our U.S. distribution network and enhances access across the Midwest, supporting physicians and patients in their evaluation of β-amyloid neuritic plaque density—a critical step in diagnosing Alzheimer’s disease and other causes of cognitive decline. Read the full press release here: https://bit.ly/4o7RVb0 #MolecularImaging #LMI #LifeMolecularImaging #Innovation #PatientCare #Lantheus #Nuclearmedicine #Radiopharmacylaunch 

“Expanding the SOFIE network is about more than just growth. Our Decatur, IL location represents a pivotal investment in the Midwest, enabling us to bring radiopharmaceuticals closer to communities, reducing wait times, and improving patient care across the region,” said William Crisp, SOFIE Vice President of Operations. We are proud to announce our partnership with Life Molecular Imaging (LMI), a Lantheus company, to bring their established amyloid PET Tracer to SOFIE's Decatur, IL site.

Scientists have developed a revolutionary gamma-ray camera that can literally see inside the human body in ways traditional X-rays and MRIs cannot. By detecting ultra-high-energy gamma radiation, the device provides sharper, deeper, and more precise images of organs and tissues. This breakthrough could dramatically improve cancer detection, heart disease diagnosis, and other critical medical imaging. Unlike older technologies, the gamma-ray camera can penetrate dense tissue without the same risks of radiation damage. The technology is also compact and potentially affordable, making it easier to bring advanced imaging to hospitals around the world, even in low-resource settings. In the future, this device could redefine how doctors diagnose and monitor diseases, offering earlier interventions and more personalized treatments. #MedicalTech #GammaRayCamera #HealthcareInnovation #Imaging #FutureOfMedicine

For World Heart Day, we’re spotlighting an innovation unveiled at last month’s European Society of Cardiology Congress 🩺 Last month in Madrid, researchers unveiled findings on an AI-enabled stethoscope trialled across more than 200 GP practices and 1.5 million patients. The device, combining ECG and acoustic sensing with cloud-based AI, could detect heart failure, atrial fibrillation, and valve disease in just 15 seconds. Compared to standard GP practice, it: 🩺 Doubled diagnoses of heart failure 🩺 Was 3.5x more likely to detect atrial fibrillation 🩺 Was nearly 2x more likely to spot valve disease That’s a huge leap for early detection, potentially allowing thousands more patients to access treatment sooner and avoid critical deterioration. What stood out most in the article is the clear message that innovation alone isn’t enough; impact comes from integration. For technology like this to fulfil its potential, it needs more than a successful trial. It requires seamless adoption into everyday clinical workflows, supported by the right digital infrastructure, training, and ongoing engagement. This is exactly where MedTech and digital health have the power to make a difference: by turning groundbreaking tools into solutions that are practical, scalable, and embedded in everyday care. Read more from the British Heart Foundation here: https://lnkd.in/ee6XrCSu #WorldHeartDay #ESC2025 #Cardiovascular #MedTech #Innovation

 Deciding what to do with indeterminate lung nodules is a challenge.                CyPath® Lung makes it easier. ✅ Noninvasive sputum collection ✅ Flow cytometry analysis ✅ 92% sensitivity | 87% specificity For patients: fewer unnecessary procedures. For physicians: clearer, faster answers. Explore how CyPath® Lung supports smarter screening in the carousel. #LungCancer #EarlyDetection #CyPathLung #Innovation